Adverum Biotechnologies, Inc. Insider Trading for June 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adverum Biotechnologies, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Adverum Biotechnologies, Inc. for June 2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 17 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | SVP,Pharmaceutical ... | Option Exercise | M | 2.75 | 500 | 1,375 | 95,000 | |
Jun 17 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | SVP,Pharmaceutical ... | Sell | S | 39.86 | 500 | 19,931 | 7,000 | 7.5 K to 7 K (-6.67 %) |
Jun 17 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | SVP,Pharmaceutical ... | Buy | M | 2.75 | 500 | 1,375 | 7,500 | 7 K to 7.5 K (+7.14 %) |
Jun 17 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 39.86 | 1,192 | 47,516 | 37,161 | 38.4 K to 37.2 K (-3.11 %) |
Jun 17 2015 | AAVL | Adverum Biotechnol ... | Schwartz Steven Daniel | Director | Sell | S | 39.86 | 16,875 | 672,671 | 367,931 | 384.8 K to 367.9 K (-4.39 %) |
Jun 16 2015 | AAVL | Adverum Biotechnol ... | Hull Hans | SVP, Business Opera ... | Option Exercise | M | 0.19 | 8,300 | 1,577 | 12,200 | |
Jun 16 2015 | AAVL | Adverum Biotechnol ... | Hull Hans | SVP, Business Opera ... | Buy | M | 0.19 | 8,300 | 1,577 | 19,620 | 11.3 K to 19.6 K (+73.32 %) |
Jun 15 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 39.97 | 1,900 | 75,939 | 522,989 | 524.9 K to 523 K (-0.36 %) |
Jun 15 2015 | AAVL | Adverum Biotechnol ... | Bain Linda | Chief Financial Off ... | Option Exercise | M | 3.15 | 3,500 | 11,025 | 233,000 | |
Jun 15 2015 | AAVL | Adverum Biotechnol ... | Bain Linda | Chief Financial Off ... | Sell | S | 39.94 | 3,500 | 139,795 | 9,000 | 12.5 K to 9 K (-28.00 %) |
Jun 15 2015 | AAVL | Adverum Biotechnol ... | Bain Linda | Chief Financial Off ... | Buy | M | 3.15 | 3,500 | 11,025 | 12,500 | 9 K to 12.5 K (+38.89 %) |
Jun 11 2015 | AAVL | Adverum Biotechnol ... | GUERIN JOHN PATRICK ET AL | Director | Sell | S | 206.00 | 699 | 143,994 | 150,000 | 150.7 K to 150 K (-0.46 %) |
Jun 11 2015 | AAVL | Adverum Biotechnol ... | GUERIN JOHN PATRICK ET AL | Director | Sell | S | 208.00 | 1 | 208 | 150,699 | 150.7 K to 150.7 K (0.00 %) |
Jun 11 2015 | AAVL | Adverum Biotechnol ... | GUERIN JOHN PATRICK ET AL | Director | Sell | S | 206.00 | 1,205 | 248,230 | 150,700 | 151.9 K to 150.7 K (-0.79 %) |
Jun 11 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 39.91 | 600 | 23,948 | 524,889 | 525.5 K to 524.9 K (-0.11 %) |
Jun 11 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 37.35 | 200 | 7,470 | 525,489 | 525.7 K to 525.5 K (-0.04 %) |
Jun 11 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 36.20 | 7,000 | 253,402 | 525,689 | 532.7 K to 525.7 K (-1.31 %) |
Jun 11 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 35.52 | 15,300 | 543,456 | 532,689 | 548 K to 532.7 K (-2.79 %) |
Jun 11 2015 | AAVL | Adverum Biotechnol ... | Chalberg Thomas W. | Chief Executive Off ... | Sell | S | 38.90 | 6,995 | 272,123 | 258,988 | 266 K to 259 K (-2.63 %) |
Jun 11 2015 | AAVL | Adverum Biotechnol ... | Chalberg Thomas W. | Chief Executive Off ... | Sell | S | 38.04 | 12,970 | 493,339 | 265,983 | 279 K to 266 K (-4.65 %) |
Jun 11 2015 | AAVL | Adverum Biotechnol ... | Chalberg Thomas W. | Chief Executive Off ... | Sell | S | 36.89 | 5,035 | 185,733 | 278,953 | 284 K to 279 K (-1.77 %) |
Jun 10 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 39.88 | 176 | 7,019 | 38,353 | 38.5 K to 38.4 K (-0.46 %) |
Jun 10 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 38.96 | 475 | 18,505 | 38,529 | 39 K to 38.5 K (-1.22 %) |
Jun 10 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 37.96 | 541 | 20,537 | 39,004 | 39.5 K to 39 K (-1.37 %) |
Jun 10 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Option Exercise | M | 2.75 | 500 | 1,375 | 95,500 | |
Jun 10 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Sell | S | 39.88 | 82 | 3,270 | 7,000 | 7.1 K to 7 K (-1.16 %) |
Jun 10 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Sell | S | 38.95 | 183 | 7,128 | 7,082 | 7.3 K to 7.1 K (-2.52 %) |
Jun 10 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Sell | S | 37.97 | 235 | 8,923 | 7,265 | 7.5 K to 7.3 K (-3.13 %) |
Jun 10 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Buy | M | 2.75 | 500 | 1,375 | 7,500 | 7 K to 7.5 K (+7.14 %) |
Jun 08 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 40.08 | 5,000 | 200,414 | 547,989 | 553 K to 548 K (-0.90 %) |
Jun 05 2015 | AAVL | Adverum Biotechnol ... | Hull Hans | SVP, Business Opera ... | Option Exercise | M | 0.19 | 2,000 | 380 | 20,500 | |
Jun 05 2015 | AAVL | Adverum Biotechnol ... | Hull Hans | SVP, Business Opera ... | Sell | S | 37.64 | 2,000 | 75,283 | 11,320 | 13.3 K to 11.3 K (-15.02 %) |
Jun 05 2015 | AAVL | Adverum Biotechnol ... | Hull Hans | SVP, Business Opera ... | Buy | M | 0.19 | 2,000 | 380 | 13,320 | 11.3 K to 13.3 K (+17.67 %) |
Jun 02 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 36.81 | 210 | 7,730 | 39,545 | 39.8 K to 39.5 K (-0.53 %) |
Jun 02 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 36.11 | 982 | 35,461 | 39,755 | 40.7 K to 39.8 K (-2.41 %) |
Jun 02 2015 | AAVL | Adverum Biotechnol ... | Schwartz Steven Daniel | Director | Sell | S | 36.81 | 3,093 | 113,854 | 384,806 | 387.9 K to 384.8 K (-0.80 %) |
Jun 02 2015 | AAVL | Adverum Biotechnol ... | Schwartz Steven Daniel | Director | Sell | S | 36.11 | 14,157 | 511,189 | 387,899 | 402.1 K to 387.9 K (-3.52 %) |